These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


280 related items for PubMed ID: 23417632

  • 1. Prevalence and clinical presentation of HIV positive female psychiatric inpatients.
    Uys H.
    Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):23-8. PubMed ID: 23417632
    [Abstract] [Full Text] [Related]

  • 2. Psychiatric symptoms and disorders in HIV infected mine workers in South Africa. A retrospective descriptive study of acute first admissions.
    Säll L, Salamon E, Allgulander C, Owe-Larsson B.
    Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):206-12. PubMed ID: 19750249
    [Abstract] [Full Text] [Related]

  • 3. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa.
    Weich L, Pienaar W.
    Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):213-7. PubMed ID: 19750250
    [Abstract] [Full Text] [Related]

  • 4. Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study.
    Haro JM, van Os J, Vieta E, Reed C, Lorenzo M, Goetz I, EMBLEM Advisory Board.
    Acta Psychiatr Scand; 2006 Feb; 113(2):112-20. PubMed ID: 16423162
    [Abstract] [Full Text] [Related]

  • 5. [Dual diagnosis in psychoactive substance abusing or dependent persons].
    Błachut M, Badura-Brzoza K, Jarzab M, Gorczyca P, Hese RT.
    Psychiatr Pol; 2013 Feb; 47(2):335-52. PubMed ID: 23888766
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population.
    Gaynes BN, Pence BW, Eron JJ, Miller WC.
    Psychosom Med; 2008 May; 70(4):505-11. PubMed ID: 18378865
    [Abstract] [Full Text] [Related]

  • 7. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL.
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [Abstract] [Full Text] [Related]

  • 8. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN, Cummings JL, Abrams BI, DeMet EM, Katz LS, Costa JF.
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [Abstract] [Full Text] [Related]

  • 9. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, Schaffer A, Connolly M, Gorman CP, Canadian Network for Mood and Anxiety Treatments.
    Bipolar Disord; 2005 Sep; 7 Suppl 3():5-69. PubMed ID: 15952957
    [Abstract] [Full Text] [Related]

  • 10. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.
    Brown ES, Jeffress J, Liggin JD, Garza M, Beard L.
    J Clin Psychiatry; 2005 Jun; 66(6):756-60. PubMed ID: 15960570
    [Abstract] [Full Text] [Related]

  • 11. Primary mania versus HIV-related secondary mania in Uganda.
    Nakimuli-Mpungu E, Musisi S, Mpungu SK, Katabira E.
    Am J Psychiatry; 2006 Aug; 163(8):1349-54; quiz 1480. PubMed ID: 16877646
    [Abstract] [Full Text] [Related]

  • 12. A history of substance abuse complicates remission from acute mania in bipolar disorder.
    Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L.
    J Clin Psychiatry; 1999 Nov; 60(11):733-40. PubMed ID: 10584760
    [Abstract] [Full Text] [Related]

  • 13. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004 Nov; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 14. Psychiatric and medical comorbidities of bipolar disorder.
    Krishnan KR.
    Psychosom Med; 2005 Nov; 67(1):1-8. PubMed ID: 15673617
    [Abstract] [Full Text] [Related]

  • 15. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R, Aragüés M, Jiménez-Arriero MA, Ponce G, Muñoz A, Bagney A, Hoenicka J, Palomo T.
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [Abstract] [Full Text] [Related]

  • 16. Assessing predictive factors for extended hospitalization at acute psychiatric admission.
    Hopko DR, Lachar D, Bailley SE, Varner RV.
    Psychiatr Serv; 2001 Oct; 52(10):1367-73. PubMed ID: 11585954
    [Abstract] [Full Text] [Related]

  • 17. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA, Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, Kupka RW, Keck PE, Leverich GS, Post RM.
    Am J Psychiatry; 2004 Aug; 161(8):1447-54. PubMed ID: 15285972
    [Abstract] [Full Text] [Related]

  • 18. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
    Brady KT, Sonne SC, Anton R, Ballenger JC.
    J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730
    [Abstract] [Full Text] [Related]

  • 19. Treatment response in nonpsychotic vs psychotic manias - A follow up study from India.
    Prabhavathy KS, Kuruvilla PK, Ravindren R, Ganesh KK, Midhun S.
    Asian J Psychiatr; 2017 Apr; 26():104-108. PubMed ID: 28483069
    [Abstract] [Full Text] [Related]

  • 20. Responding to the threat of HIV among persons with mental illness and substance abuse.
    Parry CD, Blank MB, Pithey AL.
    Curr Opin Psychiatry; 2007 May; 20(3):235-41. PubMed ID: 17415075
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.